AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12238830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (80 mg twice daily for 5 days starting from the morning of the first postoperative day)
Number of subjects: 207
Study 12238830 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (1.5 g daily for 6 days starting in the operating room just before cardiopulmonary bypass)
Number of subjects: 207
Study 12238830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol and Magnesium (both at the same dosages)
Number of subjects: 207
Study 12238830 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic agents (Control group)
Number of subjects: 207
Study 10548619 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingectomy
Number of subjects: 204
Study 10548619 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 204
Study 7696074 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.75 mg kg‐1 administered 5 or 10 min after mivacurium, or when T1 had recovered to 5, 10, 25 or 50% of control.
Number of subjects: 70
Study 7696074 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous recovery (control group).
Number of subjects: 70
Study 1708197 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 341
Study 727903 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 17
Study 727903 — intervention group
Group type: COMPARATOR
Intervention: Combined phenelzine and amitriptyline
Number of subjects: 17
Study 31295904 — intervention group
Group type: EXPERIMENTAL
Intervention: Juggling while practicing multiplication tables (intervention group)
Number of subjects: 312
Study 31295904 — intervention group
Group type: COMPARATOR
Intervention: Sedentary practice of multiplication tables (control group)
Number of subjects: 312
Study 28635196 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs)
Number of subjects: 3900
Study 28635196 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 3900
Study 25862297 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week multispecies probiotics intervention
Number of subjects: 20
Study 25862297 — intervention group
Group type: COMPARATOR
Intervention: inert placebo
Number of subjects: 20
Study 23939325 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating heart (group A)
Number of subjects: 34
Study 23939325 — intervention group
Group type: COMPARATOR
Intervention: Arrested heart (group B)
Number of subjects: 34
Study 23939325 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 21216483 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mesenchymal stem cells (BMMSCs)
Number of subjects: 41
Study 21216483 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mononuclear cells (BMMNCs)
Number of subjects: 41
Study 21216483 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 41
Study 19104202 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line chemotherapy for metastatic breast cancer
Number of subjects: 20
Study 19104202 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping strategies (work, social support, church attendance)
Number of subjects: 20
Study 17760284 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger probe (Ox‐1)
Number of subjects: 7
Study 17760284 — intervention group
Group type: COMPARATOR
Intervention: Ear probe (Ox‐1)
Number of subjects: 7
Study 17760284 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger probe (Ox‐2)
Number of subjects: 7
Study 17760284 — intervention group
Group type: COMPARATOR
Intervention: Ear probe (Ox‐2)
Number of subjects: 7
Study 17760284 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger probes (both Ox‐1 and Ox‐2)
Number of subjects: 7
Study 17760284 — intervention group
Group type: COMPARATOR
Intervention: Ear probes
Number of subjects: 7
Study 15105197 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive music therapy
Number of subjects: 123
Study 15105197 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 123
Study 15105197 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 123
Study 11446541 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard spine board
Number of subjects: 18
Study 11446541 — intervention group
Group type: COMPARATOR
Intervention: Red vacuum mattress splint
Number of subjects: 18
Study 11446541 — intervention group
Group type: COMPARATOR
Intervention: Blue vacuum mattress splint
Number of subjects: 18
Study 9498031 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial detergent with added enzymes
Number of subjects: 25
Study 9498031 — intervention group
Group type: COMPARATOR
Intervention: Trial detergent without added enzymes
Number of subjects: 25
Study 9498031 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal washing detergent
Number of subjects: 25
Study 1454497 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror training in three dimensions (Group A)
Number of subjects: 60
Study 1454497 — intervention group
Group type: COMPARATOR
Intervention: No training (Group B, Control)
Number of subjects: 60
Study 2869714 — intervention group
Group type: EXPERIMENTAL
Intervention: apalcillin
Number of subjects: 6
Study 2869714 — intervention group
Group type: EXPERIMENTAL
Intervention: piperacillin
Number of subjects: 6
Study 2869714 — intervention group
Group type: EXPERIMENTAL
Intervention: mezlocillin
Number of subjects: 6
Study 2869714 — intervention group
Group type: EXPERIMENTAL
Intervention: azlocillin
Number of subjects: 6
Study 30322737 — intervention group
Group type: EXPERIMENTAL
Intervention: Leap motion control (LMC)
Number of subjects: 16
Study 30322737 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional OT for 60min)
Number of subjects: 16
Study 29511807 — intervention group
Group type: COMPARATOR
Intervention: D-amphetamine (40 mg)
Number of subjects: 24
Study 29511807 — intervention group
Group type: COMPARATOR
Intervention: lisdexamfetamine (100 mg)
Number of subjects: 24
Study 29511807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 26370220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.3 mg/kg
Number of subjects: 0
Study 26370220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.5 mg/kg
Number of subjects: 0
Study 26370220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.1 mg/kg
Number of subjects: 0
Study 26370220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24608361 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) 60 mg/kg
Number of subjects: 32
Study 24608361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 32
Study 24608361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 32
Study 24608361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23130754 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic case finding for Atrial Fibrillation by Experimental Group practitioners
Number of subjects: 12870
Study 23130754 — intervention group
Group type: COMPARATOR
Intervention: Regular guidelines followed by Control Group practitioners
Number of subjects: 12870
Study 20073227 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-anaphylaxis Granule (AAG)
Number of subjects: 0
Study 20073227 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 0
Study 20073227 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 0
Study 17322014 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music for 60 minutes
Number of subjects: 10
Study 17322014 — intervention group
Group type: COMPARATOR
Intervention: Resting quietly for 60 minutes (Control)
Number of subjects: 10
Study 15213033 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Rhamnose
Number of subjects: 22
Study 15213033 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 22
Study 15213033 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 22
Study 11153185 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling via convection (airflow blanket)
Number of subjects: 37
Study 11153185 — intervention group
Group type: COMPARATOR
Intervention: Cooling via conduction (water-flow blanket)
Number of subjects: 37
Study 9681082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone plus granisetron (1 mg b.d. p.o.)
Number of subjects: 654
Study 9681082 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (8 mg b.d. p.o.)
Number of subjects: 654
Study 7612714 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian vein access (Group A)
Number of subjects: 87
Study 7612714 — intervention group
Group type: COMPARATOR
Intervention: Peripheral access via veins of the flexion side of the elbow (Group B)
Number of subjects: 87
Study 2774123 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-end (single hole) epidural catheters
Number of subjects: 802
Study 2774123 — intervention group
Group type: COMPARATOR
Intervention: Closed-end (three lateral holes) epidural catheters
Number of subjects: 802
Study 356968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive C. parvum immunotherapy
Number of subjects: 49
Study 356968 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonintensive C. parvum immunotherapy
Number of subjects: 49
Study 356968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no C. parvum)
Number of subjects: 49
Study 31268989 — intervention group
Group type: EXPERIMENTAL
Intervention: WPPE (with personal protective equipment, load = 8.3 kg)
Number of subjects: 19
Study 31101080 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-degree PLR position
Number of subjects: 82
Study 31101080 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-degree PLR position
Number of subjects: 82
Study 31101080 — intervention group
Group type: COMPARATOR
Intervention: 0-degree PLR position (supine)
Number of subjects: 82
Study 31101080 — intervention group
Group type: COMPARATOR
Intervention: 0-degree PLR position
Number of subjects: 82
Study 28119232 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month progressive home exercise program (EG)
Number of subjects: 108
Study 28119232 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 108
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 30 mg pioglitazone
Number of subjects: 72
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 50 mg miglitol
Number of subjects: 72
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 1 mg glimepiride
Number of subjects: 72
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 250 mg metformin
Number of subjects: 72
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 50 mg sitagliptin
Number of subjects: 72
Study 25975816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg luseogliflozin + 0.6 mg voglibose
Number of subjects: 72
Study 23118347 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 98
Study 23118347 — intervention group
Group type: COMPARATOR
Intervention: Control (drugs with inert CYP effects)
Number of subjects: 98
Study 21733529 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN-DBS)
Number of subjects: 119
Study 21733529 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment (BMT)
Number of subjects: 119
Study 19665279 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone analogue (tryptorelin or leuprorelin, 3.75 mg every 28 days)
Number of subjects: 259
Study 19665279 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low-dose monophasic oral contraceptives (ethynilestradiol, 0.03 mg plus gestoden, 0.75 mg)
Number of subjects: 259
Study 19665279 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary therapy (vitamins, minerals salts, lactic ferments, fish oil)
Number of subjects: 259
Study 19665279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 17052809 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition enriched with carotenoids (3-mg/1500kcal) for 3 months
Number of subjects: 51
Study 17052809 — intervention group
Group type: COMPARATOR
Intervention: Control group (enteral nutrition without carotenoids)
Number of subjects: 51
Study 15269070 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning before or at 12 weeks
Number of subjects: 1600
Study 15269070 — intervention group
Group type: COMPARATOR
Intervention: Weaning after 12 weeks
Number of subjects: 1600
Study 15269070 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast fed term infants weaned before 12 weeks
Number of subjects: 1600
Study 15269070 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning before or after 12 weeks
Number of subjects: 1600
Study 11764123 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible light‐cured material
Number of subjects: 10
Study 11764123 — intervention group
Group type: COMPARATOR
Intervention: Heat‐cured acrylic
Number of subjects: 10
Study 9249859 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated MShCG level (cut-off level of 2.5 MOM)
Number of subjects: 10459
Study 9249859 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated MSAFP level
Number of subjects: 10459
Study 9249859 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined elevation of MSAFP and MShCG levels
Number of subjects: 10459
Study 7831376 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-1A treatment
Number of subjects: 0
Study 3078426 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (4 mcg/Kg/L) added to cold potassium cardioplegia
Number of subjects: 24
Study 3078426 — intervention group
Group type: COMPARATOR
Intervention: Control group (cold potassium cardioplegia without nifedipine)
Number of subjects: 24
Study 29886771 — intervention group
Group type: EXPERIMENTAL
Intervention: Early removal of indwelling catheter (2 hours after cesarean section)
Number of subjects: 134
Study 29886771 — intervention group
Group type: COMPARATOR
Intervention: Delayed removal of indwelling catheter (12 hours after cesarean section)
Number of subjects: 134
Study 31194864 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 45976
Study 31194864 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 45976
Study 28821903 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery-focused video
Number of subjects: 0
Study 28821903 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-focused video
Number of subjects: 0
Study 28821903 — intervention group
Group type: COMPARATOR
Intervention: No-video control condition
Number of subjects: 0
Study 25876886 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted total intracapsular tonsillectomy (ICTE)
Number of subjects: 104
Study 25876886 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracapsular tonsillectomy (ECTE)
Number of subjects: 104
Study 23452697 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming blanket preoperatively
Number of subjects: 128
Study 23452697 — intervention group
Group type: COMPARATOR
Intervention: No forced-air warming (control group)
Number of subjects: 128
Study 21605239 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated CO(2) laser with rolling handpiece
Number of subjects: 8
Study 21605239 — intervention group
Group type: COMPARATOR
Intervention: Fractionated CO(2) laser with stamping handpiece
Number of subjects: 8
Study 19638215 — intervention group
Group type: EXPERIMENTAL
Intervention: intensive dietary restriction- plus- exercise
Number of subjects: 450
Study 19638215 — intervention group
Group type: COMPARATOR
Intervention: exercise-only
Number of subjects: 450
Study 19638215 — intervention group
Group type: COMPARATOR
Intervention: intensive dietary restriction-only
Number of subjects: 450
Study 16775510 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (RW)
Number of subjects: 9
Study 16775510 — intervention group
Group type: EXPERIMENTAL
Intervention: Dealcoholized red wine (DARW)
Number of subjects: 9
Study 16775510 — intervention group
Group type: COMPARATOR
Intervention: Polyphenols-stripped red wine (PSRW)
Number of subjects: 9
Study 16775510 — intervention group
Group type: COMPARATOR
Intervention: Ethanol-water solution (ET)
Number of subjects: 9
Study 16775510 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 9
Study 15181040 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐metHuLeptin 0.1 mg/kg
Number of subjects: 0
Study 15181040 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐metHuLeptin 0.3 mg/kg
Number of subjects: 0
Study 15181040 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐metHuLeptin 1.0 mg/kg
Number of subjects: 0
Study 15181040 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐metHuLeptin (all doses)
Number of subjects: 0
Study 11303370 — intervention group
Group type: EXPERIMENTAL
Intervention: BAM (bismuth-subcitrate, amoxycillin, and metronidazole) for 7 days
Number of subjects: 90
Study 11303370 — intervention group
Group type: EXPERIMENTAL
Intervention: LCM (lansoprazole, clarithromycin, and metronidazole) for 7 days
Number of subjects: 90
Study 11303370 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC (lansoprazole, amoxycillin, and clarithromycin) regardless of culture results
Number of subjects: 90
Study 11303370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole and two antibacterial agents chosen according to susceptibility test
Number of subjects: 90
Study 11303370 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy based on proton pump inhibitor and two antibiotics
Number of subjects: 90
Study 11303370 — intervention group
Group type: COMPARATOR
Intervention: Gastric-mucosal culture testing for sensitivity of H. pylori to antibiotics
Number of subjects: 90
Study 9291755 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional resuscitation
Number of subjects: 18
Study 8287568 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment (group I) for 12 months
Number of subjects: 83
Study 8287568 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment (group I)
Number of subjects: 83
Study 8287568 — intervention group
Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 83
Study 3535493 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight control program with self-monitoring of blood glucose levels
Number of subjects: 50
Study 3535493 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral weight control program
Number of subjects: 50
Study 29464905 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LI) program focused on controlling GWG through nutrition and activity behaviors
Number of subjects: 210
Study 29464905 — intervention group
Group type: COMPARATOR
Intervention: Usual obstetrical care (UC)
Number of subjects: 210
Study 27018313 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative fluid management
Number of subjects: 625
Study 27018313 — intervention group
Group type: COMPARATOR
Intervention: Liberal fluid management
Number of subjects: 625
Study 23956183 — intervention group
Group type: EXPERIMENTAL
Intervention: Involuntary breath stacking (IBS)
Number of subjects: 23
Study 23956183 — intervention group
Group type: COMPARATOR
Intervention: Voluntary breath stacking (VBS)
Number of subjects: 23
Study 23956183 — intervention group
Group type: COMPARATOR
Intervention: Supported breath stacking (SBS)
Number of subjects: 23
Study 22724427 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol mixed with energy drink (AmED)
Number of subjects: 80
Study 22724427 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 80
Study 22724427 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 80
Study 22724427 — intervention group
Group type: COMPARATOR
Intervention: 0.91 ml/kg vodka
Number of subjects: 80
Study 22724427 — intervention group
Group type: COMPARATOR
Intervention: 1.82 ml/kg energy drink
Number of subjects: 80
Study 21713704 — intervention group
Group type: EXPERIMENTAL
Intervention: EEN+glutamine (EEN+Gln)
Number of subjects: 80
Study 21713704 — intervention group
Group type: COMPARATOR
Intervention: EEN
Number of subjects: 80
Study 18304176 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with showering within 1 hour (group 2)
Number of subjects: 23
Study 18304176 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with showering after 4 hours (group 3)
Number of subjects: 23
Study 18304176 — intervention group
Group type: COMPARATOR
Intervention: No exercise (group 1)
Number of subjects: 23
Study 17002080 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term educational intervention on mastery goal orientation
Number of subjects: 0
Study 17002080 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 12742841 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification system for visual field abnormalities
Number of subjects: 1636
Study 10973650 — intervention group
Group type: EXPERIMENTAL
Intervention: Filshie Clip
Number of subjects: 2746
Study 10973650 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal Ring
Number of subjects: 2746
Study 8653101 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg.kg‐1)
Number of subjects: 10
Study 8653101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2067362 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine pretreatment (PP) 2 mg/kg
Number of subjects: 16
Study 2067362 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 16
Study 30683155 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-thematic coaching (training in patient-centred coaching, shared decision-making, and motivational interviewing)
Number of subjects: 0
Study 30683155 — intervention group
Group type: COMPARATOR
Intervention: State-of-the-art smoking cessation algorithm (control group)
Number of subjects: 0
Study 29030065 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic treatment (40mg bolus of furosemide)
Number of subjects: 46
Study 29030065 — intervention group
Group type: COMPARATOR
Intervention: Volume expansion (500mL of saline infusion)
Number of subjects: 46
Study 25380294 — intervention group
Group type: EXPERIMENTAL
Intervention: High 25OHD and high PA (VitD+PA+)
Number of subjects: 615